1. Abdel-Fattah M., M. Gamal-Eldeen, W.A. Helmy and MA.H. Esawy. 2012. Antitumor and antioxidant activities of levan and its derivative from the isolate Bacillus subtilis NRC1aza. Carbohydr. Polym. 89(2): 314–322.
2. Abdul Razack S., V. Velayutham and V. Thangavelu. 2013. Influ¬ence of various parameters on exopolysaccharide production from Bacillus subtilis. Int. J. Chem. Tech. Res. CODEN (USA) 5(5): 2221–2228.
3. Abou-Dobara M.I., A.A. El-Fallal, E. Toson, A. Abbas andF. El-Feky. 2014. Optimization of exopolysaccharides production by Bacillus subtilis. Pharmacol. 1: 140–148.
4. Ahmed E.F., N.M. Mansour, W.A. Helmy, W.M. El-Senousy, M.M. El-Safty and M.A. Esawy. 2010. Production of an antiviral levan from novel honey Bacillus subtilis isolates. J. Gen. Engin Bio¬technol. 8(1): 71–79.
5. Anju P., N. Milind and D.K. Santosh. 2010. Hemolysin, protease, and EPS producing pathogenic Aeromonas hydrophila strain An4 shows antibacterial activity against marine bacterial fish pathogens. J. Mar. Biol. 10: 1–9.